Genetic Variation of Glutathione S-Transferase M1 Is Associated with Patients with Ovarian Endometriosis and Endometriosis-Related Primary Infertility.

IF 1.3 4区 医学 Q4 GENETICS & HEREDITY Public Health Genomics Pub Date : 2021-01-01 Epub Date: 2021-08-12 DOI:10.1159/000517266
Hai-Bo Zhang, Yan Li, Jian-Lei Wu, Jian Zhao, Yun-Jie Tian, Shan Kang
{"title":"Genetic Variation of Glutathione S-Transferase M1 Is Associated with Patients with Ovarian Endometriosis and Endometriosis-Related Primary Infertility.","authors":"Hai-Bo Zhang,&nbsp;Yan Li,&nbsp;Jian-Lei Wu,&nbsp;Jian Zhao,&nbsp;Yun-Jie Tian,&nbsp;Shan Kang","doi":"10.1159/000517266","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim of the study was to investigate the role of the genetic variation of glutathione S-transferase M1 (GSTM1) in the development of ovarian endometriosis and endometriosis-related primary infertility risk.</p><p><strong>Methods: </strong>This case-control study included 564 women with ovarian endometriosis and 576 normal women in the control group in northern China. The polymorphism of GSTM1 was genotyped by polymerase chain reaction (PCR)/ligase detection reaction method. To assess the biological significance of polymorphisms, the level of GSTM1 mRNA expression in patients' endometrial tissues with different genotypes was detected by quantitative real-time PCR (qRT-PCR).</p><p><strong>Results: </strong>Compared with the positive genotype, the null genotype of GSTM1 was associated with the risk of developing ovarian endometriosis (OR = 1.29, 95% CI = 1.02-1.62). Further analysis showed that patients with a null genotype also had a significantly higher risk of primary infertility than patients with positive genotypes (OR = 1.59, 95% CI = 1.01-2.49). In addition, we found that GSTM1 mRNA expression was present in the endometrial tissue of all patients, but the expression level of patients with a positive genotype was nearly 10 times higher than that of patients with a negative genotype.</p><p><strong>Conclusion: </strong>Our results suggest that the GSTM1 polymorphism is not only related to the genetic susceptibility to ovarian endometriosis but also a potential molecular marker of primary infertility in patients with ovarian endometriosis.</p>","PeriodicalId":49650,"journal":{"name":"Public Health Genomics","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Genomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000517266","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 3

Abstract

Background: The aim of the study was to investigate the role of the genetic variation of glutathione S-transferase M1 (GSTM1) in the development of ovarian endometriosis and endometriosis-related primary infertility risk.

Methods: This case-control study included 564 women with ovarian endometriosis and 576 normal women in the control group in northern China. The polymorphism of GSTM1 was genotyped by polymerase chain reaction (PCR)/ligase detection reaction method. To assess the biological significance of polymorphisms, the level of GSTM1 mRNA expression in patients' endometrial tissues with different genotypes was detected by quantitative real-time PCR (qRT-PCR).

Results: Compared with the positive genotype, the null genotype of GSTM1 was associated with the risk of developing ovarian endometriosis (OR = 1.29, 95% CI = 1.02-1.62). Further analysis showed that patients with a null genotype also had a significantly higher risk of primary infertility than patients with positive genotypes (OR = 1.59, 95% CI = 1.01-2.49). In addition, we found that GSTM1 mRNA expression was present in the endometrial tissue of all patients, but the expression level of patients with a positive genotype was nearly 10 times higher than that of patients with a negative genotype.

Conclusion: Our results suggest that the GSTM1 polymorphism is not only related to the genetic susceptibility to ovarian endometriosis but also a potential molecular marker of primary infertility in patients with ovarian endometriosis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
谷胱甘肽s-转移酶M1的遗传变异与卵巢子宫内膜异位症和子宫内膜异位症相关的原发性不孕症有关
背景:本研究旨在探讨谷胱甘肽s-转移酶M1 (GSTM1)基因变异在卵巢子宫内膜异位症发生及子宫内膜异位症相关原发性不孕症风险中的作用。方法:选取中国北方地区564例卵巢子宫内膜异位症患者和576例正常女性作为对照。采用聚合酶链反应(PCR)/连接酶检测反应法对GSTM1的多态性进行基因分型。为评估多态性的生物学意义,采用实时荧光定量PCR (qRT-PCR)检测不同基因型患者子宫内膜组织中GSTM1 mRNA的表达水平。结果:与阳性基因型相比,GSTM1阴性基因型与卵巢子宫内膜异位症的发生风险相关(OR = 1.29, 95% CI = 1.02-1.62)。进一步分析显示,基因型为零的患者发生原发性不孕症的风险也明显高于基因型为阳性的患者(OR = 1.59, 95% CI = 1.01-2.49)。此外,我们发现GSTM1 mRNA在所有患者的子宫内膜组织中都有表达,但基因型阳性患者的表达水平比基因型阴性患者高近10倍。结论:GSTM1多态性不仅与卵巢子宫内膜异位症的遗传易感性有关,而且可能是卵巢子宫内膜异位症患者原发性不孕的潜在分子标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Public Health Genomics
Public Health Genomics 医学-公共卫生、环境卫生与职业卫生
CiteScore
2.90
自引率
0.00%
发文量
14
审稿时长
>12 weeks
期刊介绍: ''Public Health Genomics'' is the leading international journal focusing on the timely translation of genome-based knowledge and technologies into public health, health policies, and healthcare as a whole. This peer-reviewed journal is a bimonthly forum featuring original papers, reviews, short communications, and policy statements. It is supplemented by topic-specific issues providing a comprehensive, holistic and ''all-inclusive'' picture of the chosen subject. Multidisciplinary in scope, it combines theoretical and empirical work from a range of disciplines, notably public health, molecular and medical sciences, the humanities and social sciences. In so doing, it also takes into account rapid scientific advances from fields such as systems biology, microbiomics, epigenomics or information and communication technologies as well as the hight potential of ''big data'' for public health.
期刊最新文献
"The Biggest Struggle:" Navigating Trust and Uncertainty in Genetic Variant Interpretation. "Should I let them know I have this?": Multifaceted genetic discrimination and limited awareness of legal protections amongst individuals with hereditary cancer syndromes. Who's on your genomics research team? Consumer experiences from Australia. Development and Pilot Testing of Evidence-Based Interventions to Improve Adherence after Receiving a Genetic Result. Co-creating the experience of consent for newborn genome sequencing (The Generation Study).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1